CLEVELAND - The German-based manufacturer of the popular blood thinner Pradaxa will pay $650 million to approximately 4000 patients to settle injury lawsuits.
Boehringer Ingelheim says it settled the claims to "avoid the distraction and uncertainty of lengthy litigation."
Most patients complaints related to claims the company failed to adequately warn patients about the risk of internal bleeding.
In February, an exclusive NewsChannel5 investigation revealed Pradaxa is the most complained about drug in the United States.
Our research found more complaints were filed with the FDA about Pradaxa than any other prescription drug in both 2011 and 2012.
Since it was approved by the FDA in 2010, Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries, according to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices. The ISMP is a non-profit organization that monitors FDA reports.
Pradaxa is used to treat atrial fibrillation, a heart condition that significantly increases the risk of stroke.
Delay sought for Pilot Flying J employees
A federal judge is being asked to delay sentencing for ten former Pilot Flying J employees who previously pleaded guilty for their roles in…
Marshals investigate military sex offenders
The United States Marshals Service says it is "actively" investigating military sex offenders for failing to put their names on public…
Hosting RNC cost Tampa $676,932 in 2012
NewsChannel 5 investigators uncovers hidden costs associated with hosting the RNC convention.
Cleveland says "use of force" cut in half
Cleveland Police report instances involving "use of force" by officers have been cut in half since 2006.